For many people, yes. Anxiety does return after stopping medication, though it’s far from inevitable. In clinical trials, about 36% of people who discontinued their antidepressant experienced a relapse, compared to 16% who stayed on medication. That means roughly two-thirds of people who stop do not see their anxiety come back during the follow-up period. Your individual odds depend on how long you were treated, how you taper, and a few other factors worth understanding before you make the decision.
How Often Anxiety Returns
The most comprehensive look at this question comes from a meta-analysis of 28 relapse-prevention trials published in The BMJ. Across anxiety disorders including generalized anxiety, panic disorder, social anxiety, and OCD, 36.4% of people who switched to a placebo relapsed, while only 16.4% of those who continued their medication did. That puts the odds of relapsing roughly three times higher when you stop, but it also means the majority of people who discontinue don’t relapse within the study window.
A large UK trial that followed people on long-term antidepressants found similar numbers at the one-year mark: 56% of those who stopped their medication relapsed, compared to 39% who stayed on it. Flip that around, and 44% of people who stopped did just fine through the full year. The researchers noted that relapse risk appeared to decrease over time, suggesting that if you make it through the first several months, your chances of staying well keep improving.
Treatment Duration Matters
One of the clearest predictors of whether anxiety comes back is how long you were on medication before stopping. In one study, people who had been treated for only six months relapsed at a rate of 53.7% after discontinuation, while those treated for 12 months relapsed at just 32.4%. This is a major difference, and it’s why clinical guidelines generally recommend staying on medication for at least 6 to 12 months after your symptoms have fully resolved, not from the day you started treatment.
For panic disorder specifically, guidelines recommend at least six to eight months of treatment after achieving stability. The decision to stop typically depends on having been symptom-free for a sustained period and tapering gradually rather than stopping abruptly.
Withdrawal vs. Relapse: Telling Them Apart
One of the most confusing parts of stopping anxiety medication is figuring out whether what you’re feeling is your anxiety coming back or a temporary withdrawal reaction. These are genuinely different things, but they can feel similar, and many people (and some clinicians) mistake one for the other.
Withdrawal symptoms, sometimes called discontinuation syndrome, tend to show up within the first week after stopping or reducing your dose. They’re usually transient and resolve within one to two weeks. The hallmark signs are physical and somewhat unusual: dizziness, nausea, “brain zaps” (brief electrical-sensation feelings), flu-like symptoms, vivid dreams or nightmares, and sensory disturbances like tingling or heightened sensitivity to sound. If what you’re experiencing feels more physical than psychological, and it came on within days of your last dose, withdrawal is the more likely explanation.
A true relapse, by contrast, looks like your original anxiety disorder returning. The same worries, the same avoidance patterns, the same racing thoughts or panic symptoms you had before treatment. Relapse tends to build more gradually over weeks rather than appearing suddenly in the first few days. It also doesn’t fluctuate the way withdrawal symptoms do. Withdrawal often comes in waves, better one day and worse the next, while a relapse tends to settle in and persist.
There’s also a third possibility called rebound, where your original symptoms return temporarily but at a greater intensity than before you started medication. This happens because your brain’s counter-regulatory systems, having adapted to the drug’s presence, briefly overshoot when the drug is removed. Rebound is typically short-lived and resolves on its own.
What Happens in Your Brain
When you take an SSRI or SNRI for months or years, your brain doesn’t just passively receive extra serotonin. It actively adjusts to the new chemical environment. Serotonin receptors become less sensitive, and downstream systems involving other brain chemicals like norepinephrine, dopamine, and GABA shift to maintain a new balance. Pharmacologists call this neuroadaptation, and it’s a normal biological response to any drug that acts on the central nervous system.
The problem comes when you remove the medication. Those adaptations don’t reverse instantly. Your brain has been calibrated for a world where the drug is present, and now there’s a mismatch between how your receptors are tuned and the actual amount of signaling happening. This mismatch is what produces withdrawal symptoms, and it’s why the major factor in how long withdrawal lasts isn’t the drug’s half-life but how long it takes your brain to readjust to functioning without the medication.
This is also why tapering slowly matters so much. A gradual reduction gives your brain time to recalibrate in small steps rather than all at once.
How to Taper Safely
Most clinical guidelines recommend tapering over two to four weeks, reducing to the lowest therapeutic dose or half the minimum dose before stopping completely. However, growing evidence suggests that longer tapers, stretched over months with very small dose reductions toward the end, produce better outcomes and fewer withdrawal symptoms.
The reason for going especially slowly at lower doses is mathematical. Dropping from 20 mg to 10 mg of an SSRI reduces the drug’s effect on your serotonin system by a certain percentage. But dropping from 10 mg to zero produces a proportionally much larger change in brain activity. The relationship between dose and effect isn’t linear, so the final steps of tapering need to be the smallest.
Interestingly, the meta-analysis on anxiety relapse found no difference in relapse rates between people who tapered and those who stopped abruptly. That doesn’t mean tapering is pointless. It means tapering primarily helps with withdrawal symptoms rather than preventing a true relapse. Whether your anxiety ultimately comes back appears to depend more on the nature of your condition and how long you were treated than on how you stopped.
Who Is Most Likely to Relapse
The type of anxiety disorder you have doesn’t seem to change your relapse risk much. Panic disorder, generalized anxiety, and social anxiety all showed similar rates of return after discontinuation. What does increase your risk is a history of multiple episodes, higher baseline anxiety sensitivity (a tendency to interpret anxiety-related body sensations as dangerous), and lower overall functioning before stopping.
Guidelines are more cautious about discontinuation for people with recurrent anxiety, meaning those who’ve had multiple episodes throughout their life. If your anxiety first appeared during a stressful period and resolved cleanly with treatment, your outlook is better than someone who has experienced anxiety on and off for years.
Recognizing a Relapse Early
If your anxiety is returning rather than just producing temporary withdrawal effects, you’ll likely recognize it. The early signs mirror what brought you to treatment in the first place: persistent worry that feels difficult to control, restlessness or a sense of being on edge, trouble sleeping, difficulty concentrating, muscle tension, and an increasing urge to avoid situations that make you anxious. Some people notice digestive problems or a racing heart before they consciously register the psychological shift.
The key word is persistent. A bad day or a stressful week doesn’t mean your anxiety disorder is back. But if these symptoms are building over two to three weeks and starting to interfere with your daily life, that pattern is worth paying attention to. Catching a relapse early, before avoidance behaviors become entrenched, gives you more options for managing it, whether that means restarting medication, intensifying therapy, or both.
Therapy as a Buffer
One reason medication alone carries a relapse risk is that it treats the symptoms of anxiety without necessarily changing the thought patterns and behaviors that maintain it. Cognitive behavioral therapy, or CBT, teaches skills for managing anxious thoughts and gradually facing feared situations. People who combine medication with therapy, or who complete a course of CBT before or during tapering, tend to have better long-term outcomes because they have tools that persist after the prescription ends.
If you’re considering stopping medication, building or reinforcing these skills beforehand is one of the most practical things you can do to protect yourself. It doesn’t eliminate relapse risk, but it gives you a way to respond to early symptoms before they escalate.